AP

Arun Prasad Kandaswamy

Active Director Director DIN 10387408
DIN 10387408 First appointment Nov 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Arun Prasad Kandaswamy

Data last updated:

Arun Prasad Kandaswamy is a Director at Bhoomi Medicals And Diagnostics Private Limited (since 2023). Bhoomi Medicals And Diagnostics Private Limited reported revenue of ₹2.5 Lakh (FY 2024).

DIN 10387408
Primary Designation Director
First Appointment 09 Nov 2023
Oldest Company Age 2 yrs
Largest company Bhoomi Medicals And Diagnostics Private Limited · ₹2.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20232023₹2.5 Lakh (FY 2024)Active

Board colleagues of Arun Prasad Kandaswamy

Directorship timeline

Open interactive timeline →
Bhoomi Medicals And Diagnostics Private Limited
Premium access

Shareholding and investment profile for Arun Prasad Kandaswamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Prasad Kandaswamy

Arun Prasad Kandaswamy currently holds 1 directorship: Bhoomi Medicals And Diagnostics Private Limited (Director, since 09 Nov 2023, revenue ₹2.5 Lakh (FY 2024)).

Arun Prasad Kandaswamy was first appointed on 09 Nov 2023 as Director at Bhoomi Medicals And Diagnostics Private Limited.

The current boards of Arun Prasad Kandaswamy's companies include Bala Sundar Chintada (Bhoomi Medicals And Diagnostics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available